REFERENCES
1. Gregory EC, Valenzuela, Claudia P, Hoyert, Donna L. Fetal Mortality:
United States, 2019. National Vital Statistics Reports. 2021;70(11).
2. Ptacek I, Sebire N, Man J, Brownbill P, Heazell A. Systematic review
of placental pathology reported in association with stillbirth.
Placenta. 2014;35(8):552-62.
3. Page JM, Christiansen-Lindquist L, Thorsten V, Parker CB, Reddy UM,
Dudley DJ, et al. Diagnostic tests for evaluation of stillbirth: results
from the Stillbirth Collaborative Research Network. Obstetrics &
Gynecology. 2017;129(4):699-706.
4. Kidron D, Bernheim J, Aviram R. Placental findings contributing to
fetal death, a study of 120 stillbirths between 23 and 40 weeks
gestation. Placenta. 2009;30(8):700-4.
5. Pinar H, Goldenberg RL, Koch MA, Heim-Hall J, Hawkins HK, Shehata B,
et al. Placental findings in singleton stillbirths. Obstetrics and
gynecology. 2014;123(2 0 1):325.
6. Kulkarni VG, Sunilkumar KB, Nagaraj T, Uddin Z, Ahmed I, Hwang K, et
al. Maternal and Fetal Vascular Lesions of Malperfusion in the Placentas
Associated with Fetal and Neonatal Death: Results of a Prospective
Observational Study. American journal of obstetrics and gynecology.
2021.
7. Ernst LM. Maternal vascular malperfusion of the placental bed. Apmis.
2018;126(7):551-60.
8. Mayhew TM, Charnock-Jones D, Kaufmann P. Aspects of human
fetoplacental vasculogenesis and angiogenesis. III. Changes in
complicated pregnancies. Placenta. 2004;25(2-3):127-39.
9. Pinar H, Koch MA, Hawkins H, Heim-Hall J, Shehata B, Thorsten VR, et
al. The Stillbirth Collaborative Research Network (SCRN) placental and
umbilical cord examination protocol. American journal of perinatology.
2011;28(10):781.
10. Redline RW. Classification of placental lesions. American journal of
obstetrics and gynecology. 2015;213(4):S21-S8.
11. Reddy UM, Page GP, Saade GR, Silver RM, Thorsten VR, Parker CB, et
al. Karyotype versus microarray testing for genetic abnormalities after
stillbirth. New England Journal of Medicine. 2012;367(23):2185-93.
12. Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, et al.
Chromosomal microarray versus karyotyping for prenatal diagnosis. New
England Journal of Medicine. 2012;367(23):2175-84.
13. Dhillon R, Hillman S, Morris R, McMullan D, Williams D, Coomarasamy
A, et al. Additional information from chromosomal microarray analysis
(CMA) over conventional karyotyping when diagnosing chromosomal
abnormalities in miscarriage: A systematic review and meta‐analysis.
BJOG: An International Journal of Obstetrics & Gynaecology.
2014;121(1):11-21.
14. Parker CB, Hogue CJ, Koch MA, Willinger M, Reddy UM, Thorsten VR, et
al. Stillbirth Collaborative Research Network: design, methods and
recruitment experience. Paediatric and perinatal epidemiology.
2011;25(5):425-35.
15. Dudley DJ, Goldenberg R, Conway D, Silver RM, Saade GR, Varner MW,
et al. A new system for determining the causes of stillbirth. Obstetrics
and gynecology. 2010;116(2 0 1).
16. Pinar H, Koch MA, Hawkins H, Heim-Hall J, Abramowsky CR, Thorsten
VR, et al. The stillbirth collaborative research network postmortem
examination protocol. American journal of perinatology. 2012;29(3):187.
17. Khong TY, Mooney EE, Ariel I, Balmus NC, Boyd TK, Brundler M-A, et
al. Sampling and definitions of placental lesions: Amsterdam placental
workshop group consensus statement. Archives of pathology & laboratory
medicine. 2016;140(7):698-713.
18. Khong TY, Mooney EE, Nikkels PG, Morgan TK, Gordijn SJ. Pathology of
the placenta: a practical guide: Springer; 2019.
19. Kearney HM, Thorland EC, Brown KK, Quintero-Rivera F, South ST.
American College of Medical Genetics standards and guidelines for
interpretation and reporting of postnatal constitutional copy number
variants. Genetics in Medicine. 2011;13(7):680-5.
20. Pös O, Radvanszky J, Styk J, Pös Z, Buglyó G, Kajsik M, et al. Copy
number variation: methods and clinical applications. Applied Sciences.
2021;11(2):819.
21. Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, et
al. Technical standards for the interpretation and reporting of
constitutional copy-number variants: a joint consensus recommendation of
the American College of Medical Genetics and Genomics (ACMG) and the
Clinical Genome Resource (ClinGen). Genetics in Medicine.
2020;22(2):245-57.
22. Gurbich TA, Ilinsky VV. ClassifyCNV: a tool for clinical annotation
of copy-number variants. Scientific reports. 2020;10(1):1-7.
23. Pottinger TD, Puckelwartz MJ, Pesce LL, Robinson A, Kearns S,
Pacheco JA, et al. Pathogenic and uncertain genetic variants have
clinical cardiac correlates in diverse biobank participants. Journal of
the American Heart Association. 2020;9(3):e013808.
24. Morales A, Hershberger RE. Variants of uncertain significance:
should we revisit how they are evaluated and disclosed? : Am Heart
Assoc; 2018. p. e002169.
25. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al.
Standards and guidelines for the interpretation of sequence variants: a
joint consensus recommendation of the American College of Medical
Genetics and Genomics and the Association for Molecular Pathology.
Genetics in medicine. 2015;17(5):405-23.
26. Korteweg FJ, Bouman K, Erwich JJH, Timmer A, Veeger NJ, Ravisé JM,
et al. Cytogenetic analysis after evaluation of 750 fetal deaths:
proposal for diagnostic workup. Obstetrics & Gynecology.
2008;111(4):865-74.
27. Reddy UM, Goldenberg R, Silver R, Smith GC, Pauli RM, Wapner RJ, et
al. Stillbirth classification—developing an international consensus
for research: executive summary of a National Institute of Child Health
and Human Development workshop. Obstetrics and gynecology.
2009;114(4):901.
28. Wapner RJ, Lewis D. Genetics and metabolic causes of stillbirth.
Seminars in perinatology; 2002: Elsevier; 2002. p. 70-4.
29. Burnside RD. 22q11. 21 deletion syndromes: a review of proximal,
central, and distal deletions and their associated features. Cytogenetic
and Genome Research. 2015;146(2):89-99.
30. Fulcheri E, Gualco M, Delfino F, Pantarotto M. Placental lesions in
a case of DiGeorge sequence. Fetal diagnosis and therapy.
2006;21(1):1-7.
31. Zhang J, Zhang B, Liu T, Xie H, Zhai J. Partial trisomy 4q and
monosomy 5p inherited from a maternal translocationt (4; 5)(q33; p15) in
three adverse pregnancies. Molecular Cytogenetics. 2020;13(1):1-8.
32. Ramalingam A, Zhou X-G, Fiedler SD, Brawner SJ, Joyce JM, Liu H-Y,
et al. 16p13. 11 duplication is a risk factor for a wide spectrum of
neuropsychiatric disorders. Journal of human genetics. 2011;56(7):541-4.
33. Takeda N, Morita H, Fujita D, Inuzuka R, Taniguchi Y, Nawata K, et
al. A deleterious MYH11 mutation causing familial thoracic aortic
dissection. Human Genome Variation. 2015;2(1):1-3.
34. Guo D-C, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, Johnson RJ,
et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary
artery disease, stroke, and Moyamoya disease, along with thoracic aortic
disease. The American Journal of Human Genetics. 2009;84(5):617-27.
35. Mitchel MW, Moreno-De-Luca D, Myers SM, Levy RV, Turner S, Ledbetter
DH, et al. 17q12 recurrent deletion syndrome.
GeneReviews®[Internet]. 2020.
36. Verhave JC, Bech AP, Wetzels JF, Nijenhuis T. Hepatocyte nuclear
factor 1β–associated kidney disease: more than renal cysts and
diabetes. Journal of the American Society of Nephrology.
2016;27(2):345-53.
37. Miremberg H, Gindes L, Schreiber L, Raucher Sternfeld A, Bar J, Kovo
M. The association between severe fetal congenital heart defects and
placental vascular malperfusion lesions. Prenatal diagnosis.
2019;39(11):962-7.
38. Maslen CL. Recent Advances in Placenta–Heart Interactions.
Frontiers in physiology. 2018;9:735.
39. Zun Z, Zaharchuk G, Andescavage NN, Donofrio MT, Limperopoulos C.
Non-invasive placental perfusion imaging in pregnancies complicated by
fetal heart disease using velocity-selective arterial spin labeled MRI.
Scientific reports. 2017;7(1):1-10.
40. Araujo Junior E, Palma-Dias R, Martins W, Reidy K, da Silva Costa F.
Congenital heart disease and adverse perinatal outcome in fetuses with
confirmed isolated single functioning umbilical artery. Journal of
Obstetrics and Gynaecology. 2015;35(1):85-7.
41. Del Gobbo GF, Konwar C, Robinson WP. The significance of the
placental genome and methylome in fetal and maternal health. Human
genetics. 2019:1-14.
42. Hemberger M, Hanna CW, Dean W. Mechanisms of early placental
development in mouse and humans. Nature Reviews Genetics.
2020;21(1):27-43.
43. Denis M, Enquobahrie DA, Tadesse MG, Gelaye B, Sanchez SE, Salazar
M, et al. Placental genome and maternal-placental genetic interactions:
a genome-wide and candidate gene association study of placental
abruption. PloS one. 2014;9(12):e116346.
44. Group SCRNW. Causes of death among stillbirths. Jama.
2011;306(22):2459.